Dupilumab in Severe Chronic Hand Eczema

NCT04512339 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hand Eczema

Interventions

DRUG: Dupilumab
DRUG: Placebo

Sponsor

University Medical Center Groningen

Collaborators

[object Object]